While the rationale behind a beneficial effect of antioxidants on risk has merit, the study’s limitations prevent actionable ...

An expert panel says diabetes prevention should start long before hyperglycemia, with risk shaped across pregnancy, childhood ...

Researchers examine the efficacy of fixed-duration mosunetuzumab plus polatuzumab vedotin in patients with heavily pretreated ...

Adding waist-based central obesity measures to BMI may improve the identification of risk for multimorbidity in adults with ...

A novel spectacle lens design featuring aspherical lenslets reduced myopia progression in children by more than 70% compared with standard single-vision lenses over 24 months.

Using targeted therapy for spondyloarthritis for more than 6 months per year is not associated with an increased risk for cancer compared with using targeted therapy for shorter durations.

A reanalysis of lecanemab and donanemab trials suggests cognitive decline accelerates in open-label extensions, matching placebo rates, and challenging claims that cognitive benefits increase over ...

Real-world data revealed a high level of effectiveness on par with clinical trial data even among a high-risk population.

Researchers applied the physics of the instrument to a new device that reproduces the heart’s complex blood flow waveforms.

In a phase 1/2 study, guanabenz was associated with a 67% lower risk of losing the ability to walk in children with vanishing ...

Severe burn care is shifting beyond survival, with specialists now emphasizing functional recovery, quality of life, and long-term follow-up.

In a US cohort study of adults on anthracycline-based therapy for hematologic cancers, only 1%-2% received strategies to ...